Keyphrases
Inflammatory Pathways
100%
Pulmonary Tuberculosis
100%
Tricarboxylic Acid Cycle (TCA cycle)
100%
Interleukin-1β
75%
Succinate
75%
Pathologic
50%
Itaconate
50%
Inflammation
25%
Arachidonic Acid Metabolism
25%
Eicosanoids
25%
Phospholipase A2 (PLA2)
25%
Tissue Damage
25%
Tissue Inflammation
25%
Multidrug-resistant Tuberculosis (MDR-TB)
25%
Arachidonic Acid
25%
Metabolic Profiling
25%
Antituberculosis Chemotherapy
25%
High-resolution Metabolomics
25%
Tuberculosis Disease
25%
Acid Formation
25%
Metabolic Response
25%
Lipid Signaling
25%
Cytokine Profiling
25%
Combined Method
25%
Human Tuberculosis
25%
Acid Metabolism
25%
Metabolic Remodeling
25%
TCA Cycle Intermediates
25%
Ineffective Treatment
25%
Multi-cohort Studies
25%
Proinflammatory Lipids
25%
Metabolic Signaling Pathways
25%
Lipidomic Profiling
25%
Eicosanoid Signaling
25%
Medicine and Dentistry
Drive
100%
Lung Tuberculosis
100%
Interleukin 1
75%
Succinic Acid
75%
Diseases
75%
Metabolite
50%
Arachidonic Acid
50%
Icosanoid
50%
Itaconic Acid
50%
Cell Signaling Pathway
25%
Cytokine
25%
Phospholipase A2
25%
Anti-Inflammatory Drug
25%
Metabolomics
25%
Tuberculostatic Agent
25%
Lipidomics
25%
Multidrug Resistant Tuberculosis
25%
Biochemistry, Genetics and Molecular Biology
Drive
100%
Interleukin-1
100%
Metabolic Pathway
66%
Eicosanoid
66%
Metabolite
66%
Arachidonic Acid
66%
Phospholipase A2
33%
Cytokine
33%
Metabolomics
33%
Lipid Signaling
33%
Lipidomics
33%
Blood Plasma
33%
Anti-Inflammatory
33%
Immunology and Microbiology
Interleukin 1
100%
Metabolite
66%
Blood Plasma
33%
Cytokine
33%
Multi-Drug-Resistant Tuberculosis
33%